Orei Health joins the “Start in …” Startup Platform Program
In April 2024, Orei Health was accepted into the “Start in …” Startup Platform, a comprehensive incubation program co-financed by the European Union under the European Funds for Eastern Poland 2021–2027, Priority FEPW.01 – Entrepreneurship and Innovation, Action FEPW.01.01 – Startup Platforms for New Ideas, Component I – Incubation.
This program supports the development of innovative startups from Poland.
Through this program, we can refine our technology, validate our business model, and strengthen our market entry strategy – all while collaborating with experienced professionals who understand the challenges of building medtech solutions.
About the “Start in …” Startup Platform
The program selects the most promising ideas based on innovation, competitive advantage, business potential, the experience and qualifications of the founders, and the feasibility of the project.
Projects that address ecological or social aspects of sustainable development receive additional recognition – an important aspect that aligns with Orei Health’s mission of removing barriers to preventive healthcare on a global scale.
During the incubation period, each startup benefits from an individual incubation plan, tailored to its industry and stage of development.
Orei Health’s participation not only validates the innovation behind our work but also positions us among the leading startups in Eastern Poland working on solutions with both national and global impact.
Looking ahead
Joining “Start in …” marks a significant milestone in our journey. It strengthens our ability to deliver on our mission: making blood diagnostics painless, stress-free, and accessible anywhere in the world. With the program’s resources and expertise, we are accelerating the path to introducing Orei One device to the market – and to transforming how people experience blood collection.
